However, re-expression of SIX1 has been demonstrated in a host of distinct tumor types, including breast cancer11, rhabdomyosarcoma (RMS)12–14, and hepatocellular carcinoma15 amongst others16–20. This evidence concerns the gene SIX1 and neoplasm.